Back

Dexamethasone treatment attenuates pulmonary embolism rates in severe COVID-19 disease

22 May 2022 (14:55 - 15:40)
Organised by:
Congress Presentation Part of: Focus on the right side Clinical HFA Premium Access Heart Failure 2022

About the speaker

Photo
Assistant Professor Peter Jirak

Salzburg university hospital, Salzburg (Austria)

6 More presentations in this session

Presentation thumbnail
Myocardial work in different aetiologies of right ventricular hemodynamic overload
Mr K. Berg-Hansen (Aarhus, DK)
Abstract
Presentation thumbnail
Feasibility and safety of the antecubital venous access for right heart catheterization in patients with pulmonary hypertension
Doctor J. Grade Santos (Almada, PT)
Abstract Slides
Presentation thumbnail
COMPERA score revised: better risk estimation to better tailor therapeutics in precapillary hypertension
Doctor P. Alves da Silva (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Comparison of different clinical prognostic scores in patients with pulmonary embolism and active cancer
Doctor A. Martins (Lisbon, PT)
Abstract Slides
Presentation thumbnail
Efficacy and safety of selexipag in patients with pulmonary arterial hypertension in real-life: early results of RAMPHA study
Doctor R. Bravo-Marques (Marbella, ES)
Abstract Slides

Access the full session

Session thumbnail
Focus on the right side

The Event

Event poster

Heart Failure 2022

22 May 2022 14:55 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources